GPR157 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population derived from the HeLa host line, designed to abolish functional expression of the orphan G protein-coupled receptor GPR157. This product comprises a heterogeneous pool of cells harboring various Cas9-mediated disruptions at the target locus, providing a physiologically relevant loss-of-function model for studying GPR157-dependent signaling without the clonal artifacts associated with single-cell isolates. The polyclonal format preserves population-level genetic diversity while enabling robust interrogation of gene function in downstream assays. Researchers can leverage these cells to dissect the contribution of GPR157 to Hedgehog pathway regulation, ciliary signaling dynamics, and GPCR-mediated cellular responses in a human cervical adenocarcinoma background.
HeLa cells are a widely employed, HPV18-positive cervical epithelial adenocarcinoma line that has been instrumental in advancing cancer biology and signal transduction research. Their rapid growth, ease of transfection, and well-characterized genome make them an ideal host for generating CRISPR knockout models. The adherent, epithelial morphology and stable karyotype support reproducible experimental setups, including high-content imaging and biochemical analyses. In the context of GPR157 loss, the HeLa background offers a relevant platform to examine oncogenic signaling networks, as these cells exhibit baseline activity of the Hedgehog pathway and express core ciliary components, thereby facilitating mechanistic studies of primary cilium-associated receptor function.
GPR157 encodes an orphan GPCR that localizes to the primary cilium, where it acts as a positive regulator of Hedgehog signaling by promoting the ciliary accumulation of Smoothened (SMO). Upon pathway activation, SMO translocation into the cilium is required for the dissociation of the GLI transcription factors from their inhibitor SUFU, allowing GLI1 and GLI2 to translocate to the nucleus and drive expression of Hedgehog target genes such as PTCH1. GPR157 is thought to facilitate this process through interactions with intraflagellar transport proteins, although its direct ligand remains unidentified. As an upstream modulator of SMO trafficking, GPR157 knockdown or loss disrupts proper GLI activation and attenuates the transcriptional output of the pathway, positioning it as a critical node between GPCR signaling and ciliary-mediated signal transduction.
In the HeLa carcinoma context, GPR157 knockout cells serve as a valuable model to explore the intersection of Hedgehog pathway dysregulation and cervical cancer progression. Aberrant Hedgehog signaling has been implicated in a variety of malignancies, including glioblastoma and other aggressive tumors, where it contributes to cell proliferation, survival, and metastasis. Because HeLa cells natively express Hedgehog components and possess primary cilia, they provide a tractable system to assess how GPR157 loss impacts SMO ciliary trafficking, GLI-mediated transcription, and downstream oncogenic phenotypes. Furthermore, these cells can be used to study ciliopathy-related mechanisms, as defective ciliary receptor localization underlies several developmental disorders. The polyclonal knockout model thus enables robust investigation of both tumor cell biology and broader cilium-dependent signaling processes.
Typical applications include monitoring Hedgehog pathway activity via Gli-luciferase reporter assays, assessing protein expression changes by Western blotting for GLI1, PTCH1, or phosphorylated SMO, and quantifying transcript levels of Hedgehog target genes using RT-qPCR. Immunofluorescence microscopy can be employed to visualize SMO ciliary localization defects in the absence of GPR157, providing direct evidence of disrupted ciliary trafficking. Additionally, these cells are suitable for functional assays such as cell proliferation and migration studies to evaluate the phenotypic consequences of GPR157 knockout in cancer cells. Researchers focusing on GPCR signaling, ciliary biology, or anticancer drug screening will find this model particularly informative. For further technical specifications, alternative formats, or custom requirements, please contact Ascent Research.
